High Accuracy Indicators of Androgen Suppression Therapy Failure for Prostate Cancer—A Modeling Study

William Meade, Allison Weber, Tin Phan, Emily Hampston, Laura Figueroa Resa, John Nagy, Yang Kuang

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Prostate cancer is a serious public health concern in the United States. The primary obstacle to effective long-term management for prostate cancer patients is the eventual development of treatment resistance. Due to the uniquely chaotic nature of the neoplastic genome, it is difficult to determine the evolution of tumor composition over the course of treatment. Hence, a drug is often applied continuously past the point of effectiveness, thereby losing any potential treatment combination with that drug permanently to resistance. If a clinician is aware of the timing of resistance to a particular drug, then they may have a crucial opportunity to adjust the treatment to retain the drug’s usefulness in a potential treatment combination or strategy. In this study, we investigate new methods of predicting treatment failure due to treatment resistance using a novel mechanistic model built on an evolutionary interpretation of Droop cell quota theory. We analyze our proposed methods using patient PSA and androgen data from a clinical trial of intermittent treatment with androgen deprivation therapy. Our results produce two indicators of treatment failure. The first indicator, proposed from the evolutionary nature of the cancer population, is calculated using our mathematical model with a predictive accuracy of 87.3% (sensitivity: 96.1%, specificity: 65%). The second indicator, conjectured from the implication of the first indicator, is calculated directly from serum androgen and PSA data with a predictive accuracy of 88.7% (sensitivity: 90.2%, specificity: 85%). Our results demonstrate the potential and feasibility of using an evolutionary tumor dynamics model in combination with the appropriate data to aid in the adaptive management of prostate cancer.

Original languageEnglish (US)
Article number4033
Issue number16
StatePublished - Aug 2022


  • adaptive cancer management
  • dynamic indicator of treatment failure
  • evolutionary cell quota framework
  • mechanistic model of prostate cancer
  • predictive modeling

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'High Accuracy Indicators of Androgen Suppression Therapy Failure for Prostate Cancer—A Modeling Study'. Together they form a unique fingerprint.

Cite this